Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL6926569 | 0.95 | MEN1 (0.43) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL9517621 | 0.95 | MEN1 (0.43) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Thiosulfuric Acid SCHEMBL27724216 | 0.95 | ALDH1A1 (0.50) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Thiosulfuric Acid SCHEMBL11787332 | 0.95 | ALDH1A1 (0.50) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Thiosulfuric Acid SCHEMBL11200821 | 0.95 | ALDH1A1 (0.50) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Thiosulfuric Acid SCHEMBL4088 | 0.95 | — | — | |
| Sulfuric Acid SCHEMBL8851620 | 0.90 | MEN1 (0.36) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL8851614 | 0.90 | MEN1 (0.36) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Thiosulfuric Acid SCHEMBL3692435 | 0.90 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2AKDM4E | |
| Thiosulfuric Acid SCHEMBL8924214 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119998400-A | Polycarbonate compositions, methods for preparing the same, and articles comprising the polycarbonate compositions | 高新特殊工程塑料全球技术有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119278237-A | Anti-drip polycarbonate compositions | 高新特殊工程塑料全球技术有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118984851-A | PBT-alumina composite particles, methods, and molded parts | 高新特殊工程塑料全球技术有限公司 | 2024-11-19 | — | — | CN | disclosed |
| CN-118632900-A | Thermoplastic composition | 高新特殊工程塑料全球技术有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-116041597-B | Polybutadiene latex and ABS resin and preparation method thereof | 金发科技股份有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-116848192-A | Thermoplastic composition | 高新特殊工程塑料全球技术有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116041597-A | Polybutadiene latex and ABS resin and preparation method thereof | 金发科技股份有限公司 | 2023-05-02 | — | — | CN | disclosed |
| US-20150315188-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | MEDIVATION TECHNOLOGIES, INC. | 2015-11-05 | — | — | US | disclosed |
| EP-2887805-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | Medivation Technologies, Inc. (US) | 2015-07-01 | — | — | EP | disclosed |
| WO-2014031170-A1 | PYRIDO[4,3-B]INDOLE AND PYRIDO[3,4-B]INDOLE DERIVATIVES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031165-A1 | COMPOUNDS AND METHODS OF TREATING DIABETES | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| WO-2014031167-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-02-27 | — | — | WO | disclosed |
| EP-1608622-A4 | BIARYL SUBSTITUTED 6-MEMBERED HETEROCYLES AS SODIUM CHANNEL BLOCKERS | MERCK & CO INC (US) | 2009-04-01 | — | — | EP | disclosed |
| US-20060293339-A1 | Biaryl substituted 6-membered heterocycles as sodium channel blockers | MERCK SHARP & DOHME CORP. | 2006-12-28 | — | — | US | disclosed |
| EP-1608622-A2 | BIARYL SUBSTITUTED 6-MEMBERED HETEROCYLES AS SODIUM CHANNEL BLOCKERS | Merck & Co., Inc. (US) | 2005-12-28 | — | — | EP | disclosed |
| WO-2004084824-A2 | BIARYL SUBSTITUTED 6-MEMBERED HETEROCYLES AS SODIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2004-10-07 | — | — | WO | disclosed |
| US-4220461-A | Low temperature synthesis of vitreous bodies and their intermediates | SAMANTA BINAPANI (IN) | 1980-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150315188-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION | ADRB2, ADRA2B, ADRB1 | MEN1 1907/4885ALDH1A1 718/4885TSHR 282/4885 |
| US-20060293339-A1 | Biaryl substituted 6-membered heterocycles as sodium channel blockers | TRPV1, SCN2A, SCN2B | MEN1 2432/4885ALDH1A1 725/4885TSHR 1527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.